biotech
NICE approves Novartis and Pfizer’s rival breast cancer drugs
November 16, 2017Sales and Marketing Kisqali, Novartis, Pfizer, biotech, drugs, ibrance, pharma, pharmaceutical
NICE has announced that it has given the nod to two new treatments for breast cancer with the approval of …
Genentech cements relationship with Arvinas with $650m deal
November 16, 2017Research and Development, Sales and Marketing Arvinas, Genentech, Roche, biotech, drugs, pharma, pharmaceutical
Genentech first signed a deal with Arvinas, a biotech focused on drugs within the protein degradation class, back in 2015. …
Navigating the new Clinical Trial Regulation with DIA
November 16, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, dia, drugs, pharma, pharmaceutical
For those stakeholders involved with clinical trials in Europe, the new Clinical Trial Regulation to be introduced in 2019 will …
NHS backs innovative means of cutting diabetes risk
November 15, 2017Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical
It was World Diabetes Day yesterday and the NHS announced a new tech initiative to help those most at risk …
Promising new CAR-T therapy able to target T-cell lymphoma
November 15, 2017Research and Development Autolus, CAR T, CAR-T, biotech, drugs, pharma, pharmaceutical
The CAR-T space has progressed rapidly over the last few years, culminating in FDA approvals for Novartis and Gilead to …
FDA signals crackdown on controversial painkiller
November 15, 2017Medical Communications, Research and Development biotech, drugs, kratom, pharma, pharmaceutical
Scott Gottlieb, the FDA’s Commissioner, issued an advisory about the medicinal plant-product known as kratom. The plant is known to …
Navigating the new Clinical Trial Regulation with DIA
November 14, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, dia, drugs, pharma, pharmaceutical
For those stakeholders involved with clinical trials in Europe, the new Clinical Trial Regulation to be introduced in 2019 will …
Ex-Lilly exec Trump’s nominee for health secretary
November 14, 2017Manufacturing and Production, Medical Communications Alex Azar, Donald Trump, biotech, drugs, pharma, pharmaceutical
Alex Azar is officially President Trump’s nominee for the position as head of the Health and Human Services (HHS) agency, …
EMA Headquarters: There’s no place like home
November 13, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, biotech, brexit, drugs, pharma, pharmaceutical
With the result of the Brexit referendum, the future of the EMA’s London headquarters was cast in doubt. Now, 19 …
Novartis touts longer-lasting AMD rival to Eylea
November 13, 2017Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Novartis posted strong results for its wet age-related macular degeneration (AMD) drug, by showing superiority against Eylea in Phase 3 …
UK rates of obesity increased by 92% over two decades
November 13, 2017Research and Development, Sales and Marketing OECD, biotech, drugs, obesity, pharma, pharmaceutical
A recent report by the OECD shares concerns that the UK’s overall health looks set to face a crisis due …
Nigerian agency strongly contests that 70% of drugs are fake
November 13, 2017Manufacturing and Production, Sales and Marketing Nigeria, biotech, drugs, pharma, pharmaceutical, pwC
Nigeria’s drug regulatory body has fiercely countered claims made by Chief Economist of PwC in West Africa, Andrew Nevin, that …
Hep-B vaccine four-year battle for FDA approval is finally won
November 10, 2017Medical Communications, Sales and Marketing biotech, drugs, dynavax, hepatitis B, pharma, pharmaceutical
Dynavax had said it was the last throw of the dice for its hepatitis B vaccine, Hepislav-B – the data …
Sanofi signs $805 million deal for MS drug
November 10, 2017Medical Communications, Sales and Marketing Principia Biopharma, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi has decided to build its pipeline in neurological disorders with the agreement to develop Principia Biopharma’s BTK inhibitor candidate …
Sage scores good but not great P3 postpartum depression drug results
November 10, 2017Medical Communications, Research and Development Sage Therapeutics, biotech, drugs, pharma, pharmaceutical
Sage Therapeutics share price soared 50% on the release that its two Phase 3 trials of brexanolone showed statistically significant …
